Endocrine-Related Cancer ( 2000 ) 7 199 – 226 The EGF-CFC family : novel epidermal growth factor-related proteins in development and cancer

The EGF-CFC gene family encodes a group of structurally related proteins that serve as important competence factors during early embryogenesis in Xenopus, zebrafish, mice and humans. This multigene family consists of Xenopus FRL-1, zebrafish one-eyed-pinhead (oep), mouse cripto (Cr-1) and cryptic, and human cripto (CR-1) and criptin. FRL-1, oep and mouse cripto are essential for the formation of mesoderm and endoderm and for correct establishment of the anterior/ posterior axis. In addition, oep and cryptic are important for the establishment of left-right (L/R) asymmetry. In zebrafish, there is strong genetic evidence that oep functions as an obligatory co-factor for the correct signaling of a transforming growth factor-β (TGFβ)-related gene, nodal, during gastrulation and during L/R asymmetry development. Expression of Cr-1 and cryptic is extinguished in the embryo after day 8 of gestation except for the developing heart where Cr-1 expression is necessary for myocardial development. In the mouse, cryptic is not expressed in adult tissues whereas Cr-1 is expressed at a low level in several different tissues including the mammary gland. In the mammary gland, expression of Cr-1 in the ductal epithelial cells increases during pregnancy and lactation and immunoreactive and biologically active Cr-1 protein can be detected in human milk. Overexpression of Cr-1 in mouse mammary epithelial cells can facilitate their in vitro transformation and in vivo these Cr-1–transduced cells produce ductal hyperplasias in the mammary gland. Recombinant mouse or human cripto can enhance cell motility and branching morphogenesis in mammary epithelial cells and in some human tumor cells. These effects are accompanied by an epithelial-mesenchymal transition which is associated with a decrease in β-catenin function and an increase in vimentin expression. Expression of cripto is increased several-fold in human colon, gastric, pancreatic and lung carcinomas and in a variety of different types of mouse and human breast carcinomas. More importantly, this increase can first be detected in premalignant lesions in some of these tissues. Although a specific receptor for the EGF-CFC proteins has not yet been identified, oep depends upon an activin-type RIIB and RIB receptor system that functions through Smad-2. Mouse and human cripto have been shown to activate a ras/raf/MAP kinase signaling pathway in mammary epithelial cells. Activation of phosphatidylinositol 3-kinase and Akt are also important for the ability of CR-1 to stimulate cell migration and to block lactogenic hormone-induced expression of β-casein and whey acidic protein. In mammary epithelial cells, part of these responses may depend on the ability of CR-1 to transactivate erb B-4 and/or fibroblast growth factor receptor 1 through an src-like tyrosine kinase. Endocrine-Related Cancer (2000) 7 199–226 Online version via http://www.endocrinology.org 1351-0088/00/007–199  2000 Society for Endocrinology Printed in Great Britain Salomon et al.: The EGF-CFC family The EGF-CFC gene family A new family of genes, the EGF-CFC family, that encodes extracellular growth factor-like and/or co-receptor-like proteins has been identified in the human, mouse, frog and zebrafish. Members of this family include human cripto-1 (CR-1) (also known as teratocarcinoma-derived growth factor-1 (TDGF-1)) and criptin (unpublished Human Genome Sciences Inc. patent number S5981215), mouse cripto-1 (Cr-1/tdgf-1) and cryptic,Xenopus FRL-1 and zebrafishone-eyed pinhead(oep) (Table 1) (Ciccodicolaet al. 1989, Donoet al.1993, Kinoshitaet al.1995, Shenet al. 1997, Zhanget al. 1998). CR-1 was serendipitously isolated in a screen for glucose-6–phosphate dehydrogenase as a chimeric cDNA from a human NTERA2/D1 embryonal carcinoma cDNA library (Ciccodicolaet al. 1989). The mouse gene, Cr-1, was subsequently identified and cloned from a mouse embryo cDNA library (Dono et al.1993). The closely related mouse cryptic gene was cloned by differential RT-PCR from a mouse embryoid body-derived mesoderm cDNA library, and criptin from a human pancreatic carcinoma cDNA library (Shenet al. 1997). Similarly, Xenopus laevisFRL-1 was isolated in a functional screening in yeast with the intent of identifying fibroblast growth factor receptor-1 (FGFR-1) activating genes from a Xenopus embryonic mesoderm cDNA library (Kinoshita et al. 1995). More recently, the zebrafish oepgene has been positionally cloned and identified (Zhang et al. 1998). Genomic organization of mouse and human cripto CR-1 maps centromerically to a region on chromosome 3p21.3 that is adjacent to or possibly part of a region which Table 1 EGF-CFC family and their function. EGF-CFC proteins Function Human Cripto-1 (CR-1) Gastrulation/mammary morphogen Cryptin ? Mouse cripto-1 (Cr-1) Primitive streak A/P axial formation and positioning Mesoderm and endoderm formation Cardiomyocyte development cryptic L/R symmetry Cardiac defects/right isomerization Postnatal lethality Xenopus FRL-1 Mesoderm formation Neuroectoderm formation Zebrafish one-eyed pinhead A/P axial formation and positioning (oep) mesoderm and endoderm formation Ventral neuroectoderm L/R symmetry 200 www.endocrinology.org is frequently deleted or exhibits loss of heterozygosity (LOH) in a subpopulation of head and neck, renal, gastric, bladder, breast and lung carcinomas (Dono et al.1991, Sacconet al. 1995, Toddet al. 1996, Sekidoet al. 1998, Cuthbertet al. 1999). Interestingly, theβ-catenin gene (CTNNB1) is located at the chromosomal region 3p21.3–p22 while the activin receptor IIB is located at 3p22 (Kraus et al.1994, Bondestam et al. 1999). These two genes may be involved in intracellular signaling by EGF-CFC proteins (see below). The mouse and human cripto genes consist of six exons and five introns and possess inverted Alu and B1 sequence elements respectively, and AUUU(A)-type Kamen-like sequences in a large 3 ′ untranslated region, suggesting that they encode relatively short-lived mRNA species (Fig. 1) (Donoet al.1991, 1993). The human CR-1 coding sequence containing the six exons is 4.8 kb in length. There is an excellent conservation of the exon-intron structure in the region of exon 4 which contains the EGF-like motif, while exons 1 and 3 of the mouse are 15 and 33 nucleotides shorter respectively than the corresponding human exons (Dono et al. 1991, 1993). The 5 ′ upstream genomic sequences of mouse Cr-1 and human CR-1 between -610 and -1 from the most distal translation start sites are quite dissimilar (Baldassarreet al. 2000). Several TATA and CAAT boxes are present in the mouse Cr-1 promoter region while in the human CR-1 promoter these sequences are missing. These data suggest that regulation of expression of the mouse and human cripto genes may not be entirely similar. Multiple copies of cripto-specific sequences are present in the human and mouse genomes (Dono et al. 1991, Sacconet al. 1995, Liguori et al.1996, 1997, Scognamiglio et al.1999). At least five other human CR-1–related pseudogenes and two mouse Cr-1 pseudogenes have been identified (Scognamiglio et al. 1999). The CR-2, CR-4 and CR-5 genes are truncated at the 5′-end and have accumulated point mutations, deletions and insertions (Scognamiglioet al. 1999). These genes map to chromosomes 2q37, 6p25 and 3q22 respectively while CR-6 maps to 19q13.1. The CR-3 pseudogene which maps to the Xq21–q22 region and the mouse Cr-2 pseudogene are intronless genes that have many characteristics of a retroposon but nevertheless have the potential to code for functional proteins that differ from the proteins encoded by either CR-1 or Cr-1 by only five amino acids. CR-1 and Cr-1 encode major mRNA species of approximately 2.2 kb. In some cases, less abundant transcripts of about 1.7, 3.0, 3.2 and 3.5 kb have been detected in midgestation mouse embryos and in primary and metastatic human colon and hepatic carcinomas, suggesting that theymay arise by the use of different polyadenylation sequences, by alternative splicing or by the use of an alternative initiation site for transcription (Ciccodicolaet al. 1989, Donoet al. 1993, Johnsonet al.1994, Baldassarret al.2000). In this regard, a truncated CR-1 protein of 145 amino acids may be expressed from the 1.7 kb mRNA transcript in metastatic human Endocrine-Related Cancer (2000) 7 199–226 Figure 1 (A) Schematic diagram of the human CR-1 gene and mRNA. Hatched areas represent the six exons, with the red exon encoding EGF-like motif. Numbers represent the number of bases in each region (obtained from Baldassarre et al. 2000). (B) Amino acid sequence alignment of cripto-related proteins, zebrafish oep, mouse cripto, mouse cryptic and Xenopus FRL-1. Green and yellow bars indicate amino acid identity among 4/4 and 3/4 proteins respectively. Blue and red underline represent EGF-like motif and cysteine-rich domains respectively (data obtained from Zhang et al. 1998 and reproduced with permission of the author). (C) Sequence alignment of EGF-like motifs. Green and red shaded areas represent amino acid identity in three or more proteins and in six proteins respectively. Conservation of six cysteines noted in yellow with disulfide bonds between cysteines (Cys) 1 and 3, 2 and 4, and 5 and 6 constitute loops A, B and C respectively. Note absence of residues between Cys 1 and 2 in cripto-related proteins compared with mouse EGF. colorectal carcinomas and in hepatic colon metastases due to the use of a second CUG initiation codon (at leucine 44 in the coding sequence) that eliminates the use of the first two exons and thereby deletes 43 amino acids from the N-terminus of the protein. In the mouse, low levels of Cr-1 mRNA expression can be detected by RNAse protection assays in the adult spleen, heart, lung and in distinct regions of the brain (Dono et al. 1993, Johnsonet al.1994). Adult tissues in the human that express low levels of mRNA transcripts for the 188 amino acid isoform of CR-1 as detected by RT-PCR include

[1]  A. Schier Nodal signaling in vertebrate development. , 2003, Annual review of cell and developmental biology.

[2]  C. Niehrs,et al.  Phenotypic effects in Xenopus and zebrafish suggest that one-eyed pinhead functions as antagonist of BMP signalling , 2000, Mechanisms of Development.

[3]  A. Ebert,et al.  Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells. , 2000, Experimental cell research.

[4]  E M De Robertis,et al.  Cerberus‐like is a secreted BMP and nodal antagonist not essential for mouse development , 2000, Genesis.

[5]  J. Christian,et al.  BMP, Wnt and Hedgehog signals: how far can they go? , 2000, Current opinion in cell biology.

[6]  R. Haltiwanger,et al.  Mammalian Notch1 Is Modified with Two Unusual Forms ofO-Linked Glycosylation Found on Epidermal Growth Factor-like Modules* , 2000, The Journal of Biological Chemistry.

[7]  D. Barnes,et al.  Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers. , 2000, Cancer research.

[8]  J. Massagué,et al.  Controlling TGF-β signaling , 2000, Genes & Development.

[9]  E. D. De Robertis,et al.  Endodermal Nodal-related signals and mesoderm induction in Xenopus. , 2000, Development.

[10]  S. Soker,et al.  Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Aparício,et al.  Eomesodermin is required for mouse trophoblast development and mesoderm formation , 2000, Nature.

[12]  G. Faller,et al.  Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. , 2000, The American journal of pathology.

[13]  A. Casamassimi,et al.  EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  W. Talbot,et al.  Nodal signaling patterns the organizer. , 2000, Development.

[15]  A. Bauer,et al.  Brachyury is a target gene of the Wnt/β-catenin signaling pathway , 2000, Mechanisms of Development.

[16]  N. Horelli-Kuitunen,et al.  Assignment1 of ACVR2 and ACVR2B the human activin receptor type II and IIB genes to chromosome bands 2q22.2→q23.3 and 3p22 and the human follistatin gene (FST) to chromosome 5q11.2 by FISH , 2000, Cytogenetic and Genome Research.

[17]  Naoto Ueno,et al.  Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer , 2000, Nature.

[18]  E. Adamson,et al.  Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development , 2000, Mechanisms of Development.

[19]  A. Ebert,et al.  Cripto-1 induces apoptosis in HC-11 mouse mammary epithelial cells , 2000, Cell Death and Differentiation.

[20]  Jonathan A Raper,et al.  Semaphorins and their receptors in vertebrates and invertebrates , 2000, Current Opinion in Neurobiology.

[21]  C. Wright,et al.  Activin- and Nodal-related factors control antero–posterior patterning of the zebrafish embryo , 2000, Nature.

[22]  Scott E Fraser,et al.  The Molecular Metamorphosis of Experimental Embryology , 2000, Cell.

[23]  C. Wicking,et al.  The hedgehog signalling pathway in tumorigenesis and development , 1999, Oncogene.

[24]  M. Kasuga,et al.  A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. , 1999, Biochemical and biophysical research communications.

[25]  Randall T Moon,et al.  Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways , 1999, Oncogene.

[26]  J. Foidart,et al.  Vimentin contributes to human mammary epithelial cell migration. , 1999, Journal of cell science.

[27]  H. Sive,et al.  Mesoderm induction in Xenopus is a zygotic event regulated by maternal VegT via TGFbeta growth factors. , 1999, Development.

[28]  R. Kucherlapati,et al.  Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Talbot,et al.  Conserved requirement for EGF-CFC genes in vertebrate left-right axis formation. , 1999, Genes & development.

[30]  R. Toyama,et al.  Gastrulation in zebrafish: what mutants teach us. , 1999, Developmental biology.

[31]  A. Ebert,et al.  Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells. , 1999, Cancer research.

[32]  S. P. Oh,et al.  The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice. , 1999, Developmental biology.

[33]  W. Talbot,et al.  Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation. , 1999, Molecular cell.

[34]  A. Casamassimi,et al.  Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells. , 1999, Oncology reports.

[35]  J. Smith,et al.  Interference with brachyury function inhibits convergent extension, causes apoptosis, and reveals separate requirements in the FGF and activin signalling pathways. , 1999, Developmental biology.

[36]  S. Whittemore,et al.  Ret-dependent and -independent Mechanisms of Glial Cell Line-derived Neurotrophic Factor Signaling in Neuronal Cells* , 1999, The Journal of Biological Chemistry.

[37]  G. Martin,et al.  Differences in left-right axis pathways in mouse and chick: functions of FGF8 and SHH. , 1999, Science.

[38]  N. Perrimon,et al.  Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling , 1999, Nature.

[39]  H. Yost,et al.  Regulation of midline development by antagonism of lefty and nodal signaling. , 1999, Development.

[40]  G. Martin,et al.  Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. , 1999, Genes & development.

[41]  S. Selleck,et al.  The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila , 1999, Nature.

[42]  S. Soker,et al.  Neuropilin-1 Mediates Collapsin-1/Semaphorin III Inhibition of Endothelial Cell Motility , 1999, The Journal of cell biology.

[43]  P. Tam,et al.  Experimental analysis of the emergence of left-right asymmetry of the body axis in early postimplantation mouse embryos. , 1999, Cellular and molecular biology.

[44]  T. Gerster,et al.  Promoter activity of the zebrafish bhikhari retroelement requires an intact activin signaling pathway , 1999, Mechanisms of Development.

[45]  M. Rocchi,et al.  Assignment of human teratocarcinoma derived growth factor (TDGF) sequences to chromosomes 2q37, 3q22, 6p25 and 19q13.1 , 1999, Cytogenetic and Genome Research.

[46]  R. Kelley,et al.  The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII. , 1999, Biochemistry.

[47]  P. Donahoe,et al.  The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. , 1999, Development.

[48]  J. Gurdon,et al.  Activin as a morphogen in Xenopus mesoderm induction. , 1999, Seminars in cell & developmental biology.

[49]  B. Spencer‐Dene,et al.  Preneoplastic mammary tumor markers: Cripto and amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice , 1999, International journal of cancer.

[50]  M. Saarma,et al.  Other neurotrophic factors: Glial cell line‐derived neurotrophic factor (GDNF) , 1999, Microscopy research and technique.

[51]  Paul Polakis,et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.

[52]  G. Neufeld,et al.  Glypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165 * , 1999, The Journal of Biological Chemistry.

[53]  W. Talbot,et al.  The EGF-CFC Protein One-Eyed Pinhead Is Essential for Nodal Signaling , 1999, Cell.

[54]  M. Kessel,et al.  FGF8 functions in the specification of the right body side of the chick , 1999, Current Biology.

[55]  N. Normanno,et al.  Expression of cripto and amphiregulin in colon mucosa from high risk colon cancer families. , 1999, International journal of oncology.

[56]  T. Bouwmeester,et al.  The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals , 1999, Nature.

[57]  A. Casamassimi,et al.  EGF‐related peptides are involved in the proliferation and survival of MDA‐MB‐468 human breast carcinoma cells , 1999, International journal of cancer.

[58]  E. Adamson,et al.  Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. , 1999, Development.

[59]  M. Mercola Embryological basis for cardiac left-right asymmetry. , 1999, Seminars in cell & developmental biology.

[60]  B. Thisse,et al.  Antivin, a novel and divergent member of the TGFbeta superfamily, negatively regulates mesoderm induction. , 1999, Development.

[61]  A. Wynshaw-Boris,et al.  Cripto is required for correct orientation of the anterior–posterior axis in the mouse embryo , 1998, Nature.

[62]  M. Halpern,et al.  Induction of the zebrafish ventral brain and floorplate requires cyclops/nodal signalling , 1998, Nature.

[63]  M. Gates,et al.  Zebrafish organizer development and germ-layer formation require nodal-related signals , 1998, Nature.

[64]  J. Marden,et al.  FGF-mediated mesoderm induction involves the Src-family kinase Laloo , 1998, Nature.

[65]  Y. Saijoh,et al.  lefty-1 Is Required for Left-Right Determination as a Regulator of lefty-2 and nodal , 1998, Cell.

[66]  R. Harvey,et al.  Links in the Left/Right Axial Pathway , 1998, Cell.

[67]  D. Salomon,et al.  Heregulin‐dependent autocrine loop regulates growth of K‐ras but not erbB‐2 transformed rat thyroid epithelial cells , 1998, Journal of cellular physiology.

[68]  I B Dawid,et al.  Zebrafish nodal-related genes are implicated in axial patterning and establishing left-right asymmetry. , 1998, Developmental biology.

[69]  J. Minna,et al.  Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene , 1998, Oncogene.

[70]  M. Flannery,et al.  FGF-2 alters the fate of mouse epiblast from ectoderm to mesoderm in vitro. , 1998, Developmental biology.

[71]  C. Niehrs,et al.  Patterns and control of cell motility in the Xenopus gastrula. , 1998, Development.

[72]  E. Adamson,et al.  Cripto: roles in mammary cell growth, survival, differentiation and transformation , 1998, Cell Death and Differentiation.

[73]  F. Hamdy,et al.  The immunohistochemical detection of cripto‐1 in benign and malignant human bladder , 1998, The Journal of pathology.

[74]  E. Adamson,et al.  Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1. , 1998, Developmental biology.

[75]  P. Hoodless,et al.  Smad2 Signaling in Extraembryonic Tissues Determines Anterior-Posterior Polarity of the Early Mouse Embryo , 1998, Cell.

[76]  P. Donahoe,et al.  The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse. , 1998, Genes & development.

[77]  Alexander F. Schier,et al.  Positional Cloning Identifies Zebrafish one-eyed pinhead as a Permissive EGF-Related Ligand Required during Gastrulation , 1998, Cell.

[78]  R. Moon,et al.  Wnt and FGF pathways cooperatively pattern anteroposterior neural ectoderm in Xenopus , 1997, Mechanisms of Development.

[79]  C. Bianco,et al.  Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[80]  J. Smith,et al.  The Xenopus Brachyury promoter is activated by FGF and low concentrations of activin and suppressed by high concentrations of activin and by paired-type homeodomain proteins. , 1997, Genes & development.

[81]  L. Hennighausen,et al.  Cre-mediated gene deletion in the mammary gland. , 1997, Nucleic acids research.

[82]  L. Orci,et al.  Induction of epithelial branching tubulogenesis in vitro , 1997, Journal of cellular physiology.

[83]  N. Normanno,et al.  Anti‐sense oligonucleotides directed against EGF‐related growth factors enhance anti‐proliferative effect of conventional anti‐tumor drugs in human colon‐cancer cells , 1997, International journal of cancer.

[84]  Stefania Staibano,et al.  Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1 , 1997, Oncogene.

[85]  R. Kimmig,et al.  mRNA expression of ligands of the epidermal‐growth‐factor‐receptor in the uterus , 1997, International journal of cancer.

[86]  E. Robertson,et al.  Left-right asymmetry in vertebrates. , 1997, Current opinion in genetics & development.

[87]  S. Kuhara,et al.  Two closely‐related left‐right asymmetrically expressed genes, lefty‐1 and lefty‐2: their distinct expression domains, chromosomal linkage and direct neuralizing activity in Xenopus embryos , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[88]  J. Smith,et al.  Brachyury and the T-box genes. , 1997, Current opinion in genetics & development.

[89]  S. P. Oh,et al.  The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. , 1997, Genes & development.

[90]  J. Rossant,et al.  Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. , 1997, Development.

[91]  R. Derynck,et al.  The Type II Transforming Growth Factor-β Receptor Autophosphorylates Not Only on Serine and Threonine but Also on Tyrosine Residues* , 1997, The Journal of Biological Chemistry.

[92]  M. Sternberg,et al.  Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto. , 1997, Biochemistry.

[93]  R. Pounder,et al.  Nuclear expression of an epitope of the CCK-B/gastrin receptor. , 1997 .

[94]  H. Isaacs New perspectives on the role of the fibroblast growth factor family in amphibian development , 1997, Cellular and Molecular Life Sciences CMLS.

[95]  R. Moon,et al.  Structurally Related Receptors and Antagonists Compete for Secreted Wnt Ligands , 1997, Cell.

[96]  N. Normanno,et al.  Cripto Enhances the Tyrosine Phosphorylation of Shc and Activates Mitogen-activated Protein Kinase (MAPK) in Mammary Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[97]  S. Mackem,et al.  Two novel chick T-box genes related to mouse Brachyury are expressed in different, non-overlapping mesodermal domains during gastrulation. , 1997, Development.

[98]  W. Talbot,et al.  The one-eyed pinhead gene functions in mesoderm and endoderm formation in zebrafish and interacts with no tail. , 1997, Development.

[99]  P. Leder,et al.  A differential display strategy identifies Cryptic, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation. , 1997, Development.

[100]  D. Salomon,et al.  Expression of epidermal growth factor‐related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis , 1997, Journal of cellular physiology.

[101]  H. Sasano,et al.  Expression of Epidermal Growth Factor‐Related Proteins and Epidermal Growth Factor Receptor in Common Epithelial Ovarian Tumors , 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[102]  S. Naylor,et al.  An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. , 1996, Oncogene.

[103]  J. Weissenbach,et al.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.

[104]  H. Kuniyasu,et al.  EXPRESSION OF CRIPTO IN HUMAN GALL BLADDER LESIONS , 1996, The Journal of pathology.

[105]  J. Foidart,et al.  VIMENTIN EXPRESSION IN CERVICAL CARCINOMAS: ASSOCIATION WITH INVASIVE AND MIGRATORY POTENTIAL , 1996, The Journal of pathology.

[106]  C. Bierkamp,et al.  Cadherins and catenins in development. , 1996, Current opinion in cell biology.

[107]  Y. Sasai,et al.  Dorsoventral Patterning in Xenopus: Inhibition of Ventral Signals by Direct Binding of Chordin to BMP-4 , 1996, Cell.

[108]  P. Steinert,et al.  The function of intermediate filaments in cell shape and cytoskeletal integrity , 1996, The Journal of cell biology.

[109]  E. Dmitrovsky,et al.  Transfection with a CRIPTO anti‐sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line , 1996, International journal of cancer.

[110]  Y. Saijoh,et al.  Left–right asymmetric expression of the TGFβ-family member lefty in mouse embryos , 1996, Nature.

[111]  K. Kaga,et al.  Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. , 1996, Human pathology.

[112]  N. Normanno,et al.  Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[113]  M. Merino,et al.  Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues , 1996, International journal of cancer.

[114]  D. Salomon,et al.  Detection of amphiregulin and Cripto‐1 in mammary tumors from transgenic mice , 1996, Molecular carcinogenesis.

[115]  S. Takashima,et al.  Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas. , 1995, Japanese journal of clinical oncology.

[116]  Y. Yarden,et al.  Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2 , 1995, Molecular and cellular biology.

[117]  M. Kirschner,et al.  The identification of two novel ligands of the fgf receptor by a yeast screening method and their activity in xenopus development , 1995, Cell.

[118]  L. Larue,et al.  Lack of beta-catenin affects mouse development at gastrulation. , 1995, Development.

[119]  T. van Raaij,et al.  The cellular response to neuregulins is governed by complex interactions of the erbB receptor family , 1995, Molecular and cellular biology.

[120]  L. Bobrow,et al.  Amphiregulin and cripto overexpression in breast-cancer - relationship with prognosis and clinical and molecular-variables. , 1995, International journal of oncology.

[121]  R. Moon,et al.  Wnt4 affects morphogenesis when misexpressed in the zebrafish embryo , 1995, Mechanisms of Development.

[122]  D. Salomon,et al.  Detection and location of amphiregulin and Cripto‐1 expression in the developing postnatal mouse mammary gland , 1995, Molecular reproduction and development.

[123]  J. Rossant,et al.  fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. , 1994, Genes & development.

[124]  P. Leder,et al.  Murine FGFR-1 is required for early postimplantation growth and axial organization. , 1994, Genes & development.

[125]  J. Foidart,et al.  Epithelial‐to‐mesenchymal transition in hpv‐33‐transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase a , 1994, International journal of cancer.

[126]  D. Salomon,et al.  Members of the fatty acid binding protein family are differentiation factors for the mammary gland , 1994, The Journal of cell biology.

[127]  Susan E. Johnson,et al.  Expression of epidermal growth factor family gene members in early mouse development , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[128]  S. Takashima,et al.  Expression of cripto-1 in human colorectal adenomas and carcinomas is related to the degree of dysplasia. , 1994, International journal of oncology.

[129]  K. Grzeschik,et al.  Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. , 1994, Genomics.

[130]  L. Cantley,et al.  Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[131]  N. Normanno,et al.  Immunohistochemical detection of cripto-1, amphiregulin and transforming growth-factor-alpha in human gastric carcinomas and intestinal metaplasias. , 1994, International journal of oncology.

[132]  L. Cantley,et al.  A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling , 1994, Cell.

[133]  N. Normanno,et al.  Identification and biological characterization of an epidermal growth factor-related protein: cripto-1. , 1994, The Journal of biological chemistry.

[134]  M. Sliwkowski,et al.  Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. , 1994, The Journal of biological chemistry.

[135]  G. Merlo,et al.  Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. , 1994, British Journal of Cancer.

[136]  C. Turck,et al.  Mapping of tyrosine kinase autophosphorylation sites with synthetic peptide substrates. , 1994, Peptide research.

[137]  C. Nüsslein-Volhard,et al.  no tail (ntl) is the zebrafish homologue of the mouse T (Brachyury) gene. , 1994, Development.

[138]  I. Talbot,et al.  Immunolocalization of criptoregulin and amphiregulin in rectal-cancer - correlation with prognosis. , 1994, International Journal of Oncology.

[139]  H. Friess,et al.  Cripto, a member of the epidermal growth factor family, is over‐expressed in human pancreatic cancer and chronic pancreatitis , 1994, International journal of cancer.

[140]  M. Whitman,et al.  Mesoderm induction by activin requires FGF-mediated intracellular signals. , 1994, Development.

[141]  W. Yasui,et al.  Expression of cripto in Human Pancreatic Tumors , 1994, Japanese journal of cancer research : Gann.

[142]  D. Kimelman,et al.  Activin-mediated mesoderm induction requires FGF. , 1994, Development.

[143]  S. Nigam,et al.  HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular matrix and TGF-beta. , 1993, Developmental biology.

[144]  N. Satoh,et al.  Function of vertebrate T gene , 1993, Nature.

[145]  R. Pedersen,et al.  The role of E-cadherin and integrins in mesoderm differentiation and migration at the mammalian primitive streak. , 1993, Development.

[146]  Y. Yarden,et al.  Expression of amphiregulin, cripto-1, and heregulin-alpha in human breast-cancer cells. , 1993, International journal of oncology.

[147]  Reed J. Harris,et al.  O-linked fucose and other post-translational modifications unique to EGF modules. , 1993, Glycobiology.

[148]  Z. Su,et al.  Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. , 1993, Oncogene.

[149]  R. Moon,et al.  Synergistic principles of development: overlapping patterning systems in Xenopus mesoderm induction. , 1992, Development.

[150]  M. Sporn,et al.  Autocrine Secretion—10 Years Later , 1992, Annals of Internal Medicine.

[151]  A. Mazar,et al.  Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. , 1992, The Journal of biological chemistry.

[152]  N. Normanno,et al.  Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. , 1992, Cancer research.

[153]  S. Aaronson,et al.  Growth factors and cancer. , 1991, Science.

[154]  J. Smith,et al.  Expression of a xenopus homolog of Brachyury (T) is an immediate-early response to mesoderm induction , 1991, Cell.

[155]  M. Jaye,et al.  Ligand‐induced transphosphorylation between different FGF receptors. , 1991, The EMBO journal.

[156]  Kazuhiro Yoshida,et al.  Expression of cripto, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastrointestinal Carcinomas , 1991, Japanese journal of cancer research : Gann.

[157]  A. Ciccodicola,et al.  Isolation and characterization of the CRIPTO autosomal gene and its X-linked related sequence. , 1991, American journal of human genetics.

[158]  D. Taverna,et al.  Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[159]  D. Taverna,et al.  Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells , 1990, Molecular and cellular biology.

[160]  Silvana,et al.  Molecular characterization of a gene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratocarcinoma cells. , 1989, The EMBO journal.

[161]  A S Leong,et al.  Vimentin—a new prognostic parameter in breast carcinoma? , 1989, The Journal of pathology.

[162]  T. Nakajima,et al.  [Prognostic factors in gastric cancer]. , 1988, Gan to kagaku ryoho. Cancer & chemotherapy.

[163]  B. Groner,et al.  Prolactin regulation of beta‐casein gene expression and of a cytosolic 120‐kd protein in a cloned mouse mammary epithelial cell line. , 1988, The EMBO journal.

[164]  J. Schlessinger,et al.  Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB‐2 protein in the mammary tumor cell line SK‐BR‐3. , 1988, The EMBO journal.

[165]  Y. Yarden,et al.  Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. , 2000, Advances in cancer research.

[166]  K. M. Mulder Role of Ras and Mapks in TGFbeta signaling. , 2000, Cytokine & growth factor reviews.

[167]  Y. Saijoh,et al.  Left-right asymmetric expression of lefty2 and nodal is induced by a signaling pathway that includes the transcription factor FAST2. , 2000, Molecular cell.

[168]  T. Hirano,et al.  Zebrafish Dkk1 functions in forebrain specification and axial mesendoderm formation. , 2000, Developmental biology.

[169]  William C. Smith TGFβ inhibitors: new and unexpected requirements in vertebrate development , 1999 .

[170]  정혜근 Neuregulin induces the expression of mesodermal genes in the ectoderm of Xenopus Xenopus , 1999 .

[171]  F. Giordano,et al.  Pathological relevance of epithelial and mesenchymal phenotype plasticity. , 1999, Pathology, research and practice.

[172]  J. Bos,et al.  Signal transduction by the receptor tyrosine kinase Ret. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[173]  F. Rosa,et al.  Conversion of zebrafish blastomeres to an endodermal fate by TGF-beta-related signaling. , 1998, Current biology : CB.

[174]  W. Yasui,et al.  Abnormal expression of cripto and p53 protein in endometrial carcinoma and its precursor lesions. , 1998, European Journal of Gynaecological Oncology.

[175]  C. Angeletti,et al.  Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[176]  J. Rossant,et al.  The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. , 1998, Genes & development.

[177]  M. Desantis,et al.  Purification and characterization of a recombinant human cripto-1 protein. , 1998, Growth factors.

[178]  J. Rossant,et al.  FGF signaling in mouse gastrulation and anteroposterior patterning. , 1997, Cold Spring Harbor symposia on quantitative biology.

[179]  J. Gerhart,et al.  Formation and function of Spemann's organizer. , 1997, Annual review of cell and developmental biology.

[180]  E. Hay An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[181]  C. Viebahn Epithelio-mesenchymal transformation during formation of the mesoderm in the mammalian embryo. , 1995, Acta anatomica.

[182]  D. Taverna,et al.  Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. , 1995, Molecular endocrinology.

[183]  Y. Almirantis Left-right asymmetry in vertebrates. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[184]  K. Miyazawa,et al.  Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. , 1994, Cell adhesion and communication.

[185]  H. Kuniyasu Expression of cripto in human gastric carcinomas : An association with tumor stage and prognosis , 1994 .

[186]  K Weber,et al.  Intermediate filaments: structure, dynamics, function, and disease. , 1994, Annual review of biochemistry.

[187]  G. Fontanini,et al.  Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. , 1994, Oncogene.

[188]  J. Smith,et al.  Control of vertebrate gastrulation: inducing signals and responding genes. , 1993, Current opinion in genetics & development.

[189]  I. Dawid,et al.  Differential induction of regulatory genes during mesoderm formation in Xenopus laevis embryos. , 1993, Developmental genetics.

[190]  L. Neckers,et al.  Antisense inhibition of oncogene expression. , 1992, Critical reviews in oncogenesis.

[191]  H. N. Wright,et al.  Pharmacology and therapeutics. , 1992, Current opinion in nephrology and hypertension.